Diagnostic Imaging Devices Market to Reach $52.6 Bn by 2033,Fueled by Tech and Chronic Disease Demand|DataM Intelligence

June 19, 2025 11:15 PM AEST | By EIN Presswire
 Diagnostic Imaging Devices Market to Reach $52.6 Bn by 2033,Fueled by Tech and Chronic Disease Demand|DataM Intelligence
Image source: EIN Presswire
NEW YORK, NY, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- Market Overview

The Diagnostic Imaging Devices Market has become a cornerstone of modern healthcare, playing a critical role in disease diagnosis, treatment planning, and monitoring. From early cancer detection to neurological assessments and orthopedic evaluations, diagnostic imaging continues to empower clinicians with real-time insights into patient conditions. In 2024, the market reached a valuation of US$ 33.7 billion and is projected to hit US$ 52.6 billion by 2033, growing at a CAGR of 5.1% during the forecast period (2025–2033). Technological advancements, aging populations, and rising chronic disease burdens are key contributors to this sustained growth.

Get Latest Sample Report Pdf :
https://www.datamintelligence.com/download-sample/diagnostic-imaging-devices-market

Market Drivers are :

Rising cases of chronic illnesses, including cancer, heart disease, and neurological disorders, are fueling demand for advanced diagnostic solutions.

Growing demand for early and accurate diagnosis to improve patient outcomes and reduce healthcare costs.

Advancements in imaging technologies such as AI-driven diagnostics, portable systems, and 3D/4D imaging are revolutionizing clinical decision-making.

Rising adoption of minimally invasive diagnostic procedures among both patients and healthcare providers.

Expanding geriatric population with higher susceptibility to degenerative diseases.

Government initiatives supporting diagnostic infrastructure, especially in emerging economies.

Key Players in the Market are :

Prominent players in the Diagnostic Imaging Devices Market include:

Siemens Healthineers AG

GE HealthCare

Koninklijke Philips N.V.

CANON MEDICAL SYSTEMS CORPORATION

FUJIFILM Holdings Corporation

Medtronic plc

Hologic, Inc.

Abbott Laboratories

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Carestream Health

These companies are continuously investing in innovation, AI-integrated imaging systems, mobile solutions, and partnerships to expand their global reach.

Market Segmentation :

By Modality

X-ray Imaging Systems
Computed Tomography (CT) Scanners
Ultrasound Systems
Magntic Resonance Imaging (MRI)
Nuclear Imaging (PET, SPECT)
Mammography Systems

By Application

Oncology
Cardiology
Neurology
Orthopedics
Obstetrics and Gynecology
Others

By End-User

Hospitals
Diagnostic Centers
Ambulatory Surgical Centers
Academic and Research Institutions

Latest News of USA -

In March 2024, GE HealthCare launched an AI-enhanced CT scanner tailored for rapid stroke diagnosis, receiving FDA approval for emergency medical use.

Philips USA partnered with several hospital networks to deploy mobile MRI units in underserved rural regions to improve access to diagnostic care.

The U.S. Centers for Medicare & Medicaid Services (CMS) expanded reimbursement codes to include remote image interpretation for teleradiology, promoting tele-imaging services.

Latest News of Japan -

In 2024, Canon Medical Systems Corporation launched an AI-based ultrasound system that adjusts image settings in real time, enhancing diagnostic accuracy in prenatal care.

Fujifilm Holdings collaborated with Japanese university hospitals to pilot a cloud-based diagnostic imaging repository aimed at faster cross-institutional consultations.

The Japanese Ministry of Health increased subsidies for hospitals upgrading to digital mammography systems, boosting breast cancer screening efforts nationwide.

Recent Key Developments are :

Siemens Healthineers introduced a new generation of PET/CT systems with lower radiation exposure and faster scan times.

Hologic released a portable breast imaging system for use in community-based and mobile health clinics.

Shenzhen Mindray launched a handheld ultrasound device with built-in AI, targeting primary care practitioners in developing markets.

Medtronic received CE marking for an advanced neurological imaging module used in spinal surgeries.

Carestream Health announced an upgrade to its radiology information system (RIS) integrating advanced analytics and workflow automation.

Conclusion ;-

The Diagnostic Imaging Devices Market is experiencing robust growth, driven by a combination of medical necessity and technological innovation. The evolution of imaging from basic X-rays to AI-assisted diagnostic systems underscores the industry’s shift toward precision and efficiency. With governments and private players investing heavily in infrastructure, the next phase of growth will likely focus on portability, affordability, and patient-centric solutions. As chronic disease rates rise and healthcare systems move toward early intervention, diagnostic imaging remains indispensable to improving global health outcomes.

Related Reports: -

Diagnostic Imaging Market

MRI Contrast Media Agents Market

Sai Kumar
DataM Intelligence 4market Research LLP
+1 877-441-4866
email us here
Visit us on social media:
LinkedIn
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.